Burden of elevated lipoprotein(a) among patients with atherosclerotic cardiovascular disease: Evidence from a systematic literature review and feasibility assessment of meta-analysis.

Orfanos, Panagiotis; Fonseca, Ana Filipa; Hu, Xingdi; Gautam, Raju; Montgomery, Glenn; Studer, Rachel; Kaur, Japinder; Saxena, Nehul; Kaushik, Nitin

Burden of elevated lipoprotein(a) among patients with atherosclerotic cardiovascular disease: Evidence from a systematic literature review and feasibility assessment of meta-analysis.

Orfanos, Panagiotis; Fonseca, Ana Filipa; Hu, Xingdi; Gautam, Raju; Montgomery, Glenn; Studer, Rachel; Kaur, Japinder; Saxena, Nehul; Kaushik, Nitin.

Affiliation

Orfanos P; Value and Access, Novartis Pharma AG, Basel, Switzerland.
Fonseca AF; Value and Access, Novartis Pharma AG, Basel, Switzerland.
Hu X; Value and Access, Novartis Pharmaceutical Corporation, East Hanover, New Jersey, United States of America.
Gautam R; Value and Access, Novartis Healthcare Pvt. Ltd., Hyderabad, India.
Montgomery G; Value and Access, Novartis Pharma AG, Basel, Switzerland.
Studer R; Value and Access, Novartis Pharma AG, Basel, Switzerland.
Kaur J; Value and Access, Novartis Healthcare Pvt. Ltd., Hyderabad, India.
Saxena N; Value and Access, Novartis Healthcare Pvt. Ltd., Hyderabad, India.
Kaushik N; Value and Access, Novartis Healthcare Pvt. Ltd., Hyderabad, India.

PLoS One ; 18(11): e0294250, 2023.

Article de En | MEDLINE | ID: mdl-37983217

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladies cardiovasculaires / Accident vasculaire cérébral / Athérosclérose Type d'étude: Systematic_reviews Limites: Humans Langue: En Journal: PLoS One Sujet du journal: CIENCIA / MEDICINA Année: 2023 Type de document: Article Pays d'affiliation: Suisse Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google